Anika Therapeutics, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Anika Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Anika Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -48.1 %, a 442% decline year-over-year.
  • Anika Therapeutics, Inc. annual Return On Equity for 2023 was -32 %, a 515% decline from 2022.
  • Anika Therapeutics, Inc. annual Return On Equity for 2022 was -5.2 %, a 459% decline from 2021.
  • Anika Therapeutics, Inc. annual Return On Equity for 2021 was 1.45 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -32 -26.8 -515% Jan 1, 2023 Dec 31, 2023
2022 -5.2 -6.65 -459% Jan 1, 2022 Dec 31, 2022
2021 1.45 +9.87 Jan 1, 2021 Dec 31, 2021
2020 -8.42 -18.4 -184% Jan 1, 2020 Dec 31, 2020
2019 9.98 +2.7 +37.1% Jan 1, 2019 Dec 31, 2019
2018 7.28 -5.57 -43.4% Jan 1, 2018 Dec 31, 2018
2017 12.8 -2.71 -17.4% Jan 1, 2017 Dec 31, 2017
2016 15.6 -0.16 -1.02% Jan 1, 2016 Dec 31, 2016
2015 15.7 -7.27 -31.6% Jan 1, 2015 Dec 31, 2015
2014 23 +6.4 +38.6% Jan 1, 2014 Dec 31, 2014
2013 16.6 +5.16 +45.1% Jan 1, 2013 Dec 31, 2013
2012 11.4 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.